- Home
- RCUS vs UP Comparison
RCUS vs UP Comparison
Compare RCUS & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- UP
- Stock Information
- Founded
- RCUS 2015
- UP 2013
- Country
- RCUS United States
- UP United States
- Employees
- RCUS N/A
- UP N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- UP Aerospace
- Sector
- RCUS Health Care
- UP Consumer Discretionary
- Exchange
- RCUS Nasdaq
- UP Nasdaq
- Market Cap
- RCUS 1.4B
- UP 1.5B
- IPO Year
- RCUS 2018
- UP N/A
- Fundamental
- Price
- RCUS $15.52
- UP $1.81
- Analyst Decision
- RCUS Buy
- UP
- Analyst Count
- RCUS 12
- UP 0
- Target Price
- RCUS $34.50
- UP N/A
- AVG Volume (30 Days)
- RCUS 755.7K
- UP 1.3M
- Earning Date
- RCUS 11-06-2024
- UP 11-07-2024
- Dividend Yield
- RCUS N/A
- UP N/A
- EPS Growth
- RCUS N/A
- UP N/A
- EPS
- RCUS N/A
- UP N/A
- Revenue
- RCUS $263,000,000.00
- UP $833,669,000.00
- Revenue This Year
- RCUS $127.13
- UP $38.03
- Revenue Next Year
- RCUS N/A
- UP $25.66
- P/E Ratio
- RCUS N/A
- UP N/A
- Revenue Growth
- RCUS 119.17
- UP N/A
- 52 Week Low
- RCUS $13.52
- UP $1.55
- 52 Week High
- RCUS $20.31
- UP $6.08
- Technical
- Relative Strength Index (RSI)
- RCUS 44.11
- UP 36.08
- Support Level
- RCUS $14.78
- UP $2.04
- Resistance Level
- RCUS $18.07
- UP $2.05
- Average True Range (ATR)
- RCUS 0.96
- UP 0.14
- MACD
- RCUS -0.16
- UP -0.05
- Stochastic Oscillator
- RCUS 22.32
- UP 11.97
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About UP Wheels Up Experience Inc.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.